IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the world’s leading manufacturer and distributor of dental lasers, today announced that on July 13, 2014, Jeffrey M. Nugent, the Company’s Acting Chief Executive Officer, received options to purchase 172,282 shares of the Company’s common stock with an exercise price of $1.98 per share, the closing price per share on July 10, 2014. In addition, Mr. Nugent received an award of restricted stock units (“RSUs”) with respect to 37,879 shares of the Company’s common stock. One-sixth of the stock options and the RSUs vest immediately, with the remaining five-sixths vesting ratably on a monthly basis over a twelve-month period ending on July 13, 2015, subject to Mr. Nugent’s continued service with the Company through the applicable vesting dates.
Help employers find you! Check out all the jobs and post your resume.
